As of 2025-07-06, the Fair Value of Jeil Pharma Holdings Inc (002620.KS) is -15,312.05 KRW. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 8,820.00 KRW, the upside of Jeil Pharma Holdings Inc is -273.61%.
With the market price of 8,820.00 KRW and our fair value calculation, Jeil Pharma Holdings Inc (002620.KS) is not a good investment. Investing in 002620.KS stocks now will result in a potential loss of 273.61%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | 11,431.00 | -3,482.41 | -74,555.74 | -16,249.74 | -51,159.36 | -26,803.25 |
| YoY growth | 112.63% | -130.46% | -2,040.92% | 78.20% | -214.83% | -439.08% |
| Market Cap (mil) | 140,855.40 |
| P/E | |
| Forward P/E |
| EPS | -3,062.41 |
| Avg earnings growth rate | -439.08% |
| TTM earnings | -48,906.71 |